Carisma Therapeutics Appoints Interim VP of Finance
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Carisma Therapeutics ( (CARM) ) has issued an announcement.
Carisma Therapeutics Inc. has entered into a master services agreement with Danforth Global, Inc. and Danforth Advisors, LLC to receive finance and accounting services from Natalie McAndrew, who will serve as the interim Vice President of Finance and principal financial officer. This strategic appointment is expected to bolster the company’s financial management capabilities, enhancing its operational efficiency and potentially impacting its industry standing positively.
More about Carisma Therapeutics
YTD Price Performance: -86.38%
Average Trading Volume: 222,366
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.66M
See more insights into CARM stock on TipRanks’ Stock Analysis page.
